Professor of Pediatrics and Pathology
University of Michigan
Ann Arbor, Michigan, United States
Dr Steven Pipe is a Professor and the Laurence A. Boxer Research Professor of Pediatrics and Professor of Pathology at the University of Michigan, Ann Arbor, Michigan, USA. He is the medical director of the Pediatric Hemophilia and Coagulation Disorders Program and medical director of the Special Coagulation Laboratory. His clinical interests include bleeding and thrombotic disorders and congenital vascular anomalies. Dr Pipe also directs a basic research lab investigating coagulation factor VIII and the molecular mechanisms of hemophilia A. He has been actively involved in clinical trials with novel therapeutics for hemophilia including gene therapy. He was the 2015 recipient of the Leadership in Research Award from the National Hemophilia Foundation. He has served on the Board of Directors for the Hemostasis and Thrombosis Research Society, as Chair of the Board of Directors for the American Thrombosis and Hemostasis Network and most recently as Chair of the Medical and Scientific Advisory Council to the National Hemophilia Foundation.
Saturday, June 22, 2024
13:30 – 13:45 ICT
Sunday, June 23, 2024
09:45 – 10:00 ICT
PB0249 - Development of the first small molecule therapy for the treatment of hemophilia A and B
Sunday, June 23, 2024
13:45 – 14:45 ICT
Sunday, June 23, 2024
13:45 – 14:45 ICT
OC 30.2 - Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1
Monday, June 24, 2024
09:45 – 10:00 ICT
Monday, June 24, 2024
10:00 – 10:15 ICT
PB0500 - Communicating gene editing in hemophilia: development of a universal lexicon
Monday, June 24, 2024
13:45 – 14:45 ICT
PB0537 - Development of novel gene editing lexicon for hemophilia: methodology and results
Monday, June 24, 2024
13:45 – 14:45 ICT
OC 40.2 - Incidence of thrombotic events in the fitusiran clinical development program
Monday, June 24, 2024
15:00 – 15:15 ICT
Monday, June 24, 2024
15:15 – 15:30 ICT
SSC 018.10 - Potential for future readjudication of malignant cases
Monday, June 24, 2024
17:55 – 18:05 ICT